Prof. Daniel Chambers from the Queensland Lung Transplant Service, in The Prince Charles Hospital in Brisbane, Australia, debunks a few myths about lung transplantations with some pulmonary fibrosis  patients and other patients with lung complications: Myth 1. “Lung Transplantations are experimental treatments.” Lung transplantation was revolutionary when it was…
5 Myths About Lung Transplantation
A case report of a woman with pulmonary fibrosis and a rare telomere mutation raised the possibility that telomere-associated fibrosis can be observed without shortened telomeres. The study, “TINF2 Gene Mutation in a Patient with Pulmonary Fibrosis“, published in the journal Case Reports in Pulmonology, proposed that…
Pulmonary fibrosis is a channel dedicated to spreading awareness about this life-threatening heart and lung condition. Meet Mark, a father of two who shares his story of resilience and strength. In 2014, his health began rapidly declining and he found himself limited to his bed for…
Professor Jürgen Behr, from the University of Munich, Germany, talks in this video by Boehringer Ingelheim Idiopathic Pulmonary Fibrosis about idiopathic pulmonary fibrosis, describing what the disease is, how it affects patients and shares some useful insights about the ongoing processes in the lungs…
Researchers at Yale School of Medicine, Boston University School of Medicine, and other institutions applied an integrative genomic approach to study chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) to uncover the possible shared biological mechanisms in the two disorders. Findings suggested a common genetic network to the…
Nebraska Medicine shared this video of Donna Jacobsen, of Winside, Nebraska, who was the first patient to be added to the lung transplant waiting list at Nebraska Medicine. Diagnosed with idiopathic pulmonary fibrosis in 2012, Donna first had a feeling something was wrong when…
In this well-made animation video by Hurd Studios, find out more about pulmonary fibrosis, thoughts on how its mechanisms are triggered to develop the disease, potential associated factors, and how the disease behaves toward the lungs in different stages of development. Learn more about pulmonary fibrosis: https://bit.ly/PNewsToday…
Researchers at the University of Birmingham, United Kingdom, found that CD248 — a surface marker expressed on fibroblast cells in the lung — might also serve as a marker of disease severity in patients with idiopathic pulmonary fibrosis (IPF). The findings also indicate that CD248 might be a suitable…
In this video from Thorax (the youtube channel of Thorax journal), watch Professor Viswanathan (Nati) Natarajan, from the University of Illinois, Chicago, talk about idiopathic pulmonary fibrosis, a chronic and progressive lung disease for which the prognosis is poor and diagnosis is difficult to conduct. Prof. Viswanathan’s…
Early pulmonary rehabilitation is extremely important to idiopathic pulmonary fibrosis patients. Thorax shared this video in 2014, where Julia Bott, Respiratory Care Team, Surrey PCT, explains the importance of pulmonary rehabilitation and the impact it can have on patients. Learn more about…
